Biotechnology company Moderna (NASDAQ:MRNA) beat Wall Street’s revenue expectations in Q3 CY2025, but sales fell by 45.4% year on year to $1.02 billion. On the other hand, the company’s full-year ...

A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine ...

Some cancer patients who took 'checkpoint inhibitors' and received the COVID-19 vaccine saw surprising results.

Liberty and tyranny are the subjects of this week's Newsmax Rising Bestsellers, explaining how a popular governor introduced ...

The team used the AMG1541 LNP to deliver an mRNA influenza vaccine in mice. They compared this vaccine’s effectiveness to a flu vaccine made with the lipid SM-102, which is FDA-approved and was used ...

A new lipid nanoparticle could make mRNA vaccines more effective and potentially lower the cost per dose. New research suggests an mRNA influenza vaccine delivered with the new particle could generate ...

A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...

A: A Democratic proposal would restore almost $5 billion in unused funding for foreign aid that President Donald Trump let expire on Sept. 30. The proposal did not specify which international projects ...

Following restricted vaccine approvals and changes to CDC immunization schedules, Merck, Pfizer, GSK and Sanofi are all ...

For children, the safer path during the pandemic wasn’t a roll of the dice with infection - it was vaccination.

In the study, published in Science Translational Medicine on Nov. 5, researchers identified proteins expressed on the surface ...